// App-Quantinova.ai

: Late Breaking Abstract - Identification of patients with COPD who benefit from benralizumab

Researchers

Presenter

  • Gerard J. Criner

Principal Investigators

  • Bartolome R. Celli

  • Dave Singh

  • Maria Jison

  • Natalya Makulova

  • Vivian H. Shih

  • Laura Brooks

  • Peter Barker

  • Ubaldo J. Martin

  • Paul Newbold

Medical Centers

  • Lewis Katz School of Medicine at Temple University, Philadelpha , United States of America

  • Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston, United States of America

  • University of Manchester, Manchester University Foundation Trust NHS Hospital, Manchester, United Kingdom,

  • AstraZeneca Gaithersburg, Gaithersburg, United States of America

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • Benralizumab

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved